BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27932629)

  • 1. Breathlessness during daily activity: The psychometric properties of the London Chest Activity of Daily Living Scale in patients with advanced disease and refractory breathlessness.
    Reilly CC; Bausewein C; Garrod R; Jolley CJ; Moxham J; Higginson IJ
    Palliat Med; 2017 Oct; 31(9):868-875. PubMed ID: 27932629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and cost effectiveness of a Breathlessness Intervention Service for patients with advanced non-malignant disease and their informal carers: mixed findings of a mixed method randomised controlled trial.
    Farquhar MC; Prevost AT; McCrone P; Brafman-Price B; Bentley A; Higginson IJ; Todd CJ; Booth S
    Trials; 2016 Apr; 17():185. PubMed ID: 27044249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial.
    Higginson IJ; Bausewein C; Reilly CC; Gao W; Gysels M; Dzingina M; McCrone P; Booth S; Jolley CJ; Moxham J
    Lancet Respir Med; 2014 Dec; 2(12):979-87. PubMed ID: 25465642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial.
    Bausewein C; Jolley C; Reilly C; Lobo P; Kelly J; Bellas H; Madan P; Panell C; Brink E; De Biase C; Gao W; Murphy C; McCrone P; Moxham J; Higginson IJ
    BMC Pulm Med; 2012 Sep; 12():58. PubMed ID: 22992240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To What Extent Do the NRS and CRQ Capture Change in Patients' Experience of Breathlessness in Advanced Disease? Findings From a Mixed-Methods Double-Blind Randomized Feasibility Trial.
    Lovell N; Etkind SN; Bajwah S; Maddocks M; Higginson IJ
    J Pain Symptom Manage; 2019 Sep; 58(3):369-381.e7. PubMed ID: 31201877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in the cost of formal and informal health care for patients with advanced chronic disease and refractory breathlessness: A cross-sectional secondary analysis.
    Dzingina MD; Reilly CC; Bausewein C; Jolley CJ; Moxham J; McCrone P; Higginson IJ; Yi D
    Palliat Med; 2017 Apr; 31(4):369-377. PubMed ID: 28190370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.
    Tabberer M; Brooks J; Wilcox T
    Health Qual Life Outcomes; 2015 Oct; 13():177. PubMed ID: 26520062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The London Chest Activity of Daily Living scale cut-off point to discriminate functional status in patients with chronic obstructive pulmonary disease.
    Gulart AA; Munari AB; Klein SR; Venâncio RS; Alexandre HF; Mayer AF
    Braz J Phys Ther; 2020; 24(3):264-272. PubMed ID: 30948247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Breathlessness in Lung Cancer: Psychometric Properties of the Dyspnea-12 Questionnaire.
    Tan JY; Yorke J; Harle A; Smith J; Blackhall F; Pilling M; Molassiotis A
    J Pain Symptom Manage; 2017 Feb; 53(2):208-215. PubMed ID: 27720789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized breathlessness interventions may improve outcomes in patients with advanced COPD.
    Qian MYY; Politis J; Thompson M; Wong D; Le B; Irving L; Smallwood N
    Respirology; 2018 Dec; 23(12):1146-1151. PubMed ID: 29763515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What influenced people with chronic or refractory breathlessness and advanced disease to take part and remain in a drug trial? A qualitative study.
    Lovell N; Etkind SN; Bajwah S; Maddocks M; Higginson IJ
    Trials; 2020 Feb; 21(1):215. PubMed ID: 32087745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the French version of the London Chest Activity of Daily Living scale and the Dyspnea-12 questionnaire.
    Beaumont M; Couturaud F; Jego F; Pichon R; Le Ber C; Péran L; Rogé C; Renault D; Narayan S; Reychler G
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1399-1405. PubMed ID: 29750026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial.
    Farquhar MC; Prevost AT; McCrone P; Brafman-Price B; Bentley A; Higginson IJ; Todd C; Booth S
    BMC Med; 2014 Oct; 12():194. PubMed ID: 25358424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease.
    Yorke J; Swigris J; Russell AM; Moosavi SH; Ng Man Kwong G; Longshaw M; Jones PW
    Chest; 2011 Jan; 139(1):159-64. PubMed ID: 20595454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial.
    Visca D; Tsipouri V; Mori L; Firouzi A; Fleming S; Farquhar M; Leung E; Maher TM; Cullinan P; Hopkinson N; Wells AU; Banya W; Whitty JA; Adamali H; Spencer LG; Sestini P; Renzoni EA
    Trials; 2017 Apr; 18(1):201. PubMed ID: 28454553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of the London Chest Activity of Daily Living scale for adults with asthma.
    Puzzi VC; Oliveira JM; Alves TB; Silva JPDC; Pedroso A; Furlanetto KC
    J Asthma; 2024 Jan; 61(1):1-9. PubMed ID: 37417908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of episodic breathlessness as reported by patients with advanced chronic obstructive pulmonary disease and lung cancer: Results of a descriptive cohort study.
    Weingärtner V; Scheve C; Gerdes V; Schwarz-Eywill M; Prenzel R; Otremba B; Mühlenbrock J; Bausewein C; Higginson IJ; Voltz R; Herich L; Simon ST;
    Palliat Med; 2015 May; 29(5):420-8. PubMed ID: 25634633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of home-based physiotherapy interventions on breathlessness during activities of daily living in severe COPD: a systematic review.
    Thomas MJ; Simpson J; Riley R; Grant E
    Physiotherapy; 2010 Jun; 96(2):108-19. PubMed ID: 20420957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of respiratory health-related quality of life in patients with intractable breathlessness due to advanced cancer or advanced COPD.
    Javadzadeh S; Chowienczyk S; Booth S; Farquhar M
    BMJ Support Palliat Care; 2016 Mar; 6(1):105-8. PubMed ID: 26685116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled equivalence trial to determine the effectiveness and cost-utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX).
    Cross J; Elender F; Barton G; Clark A; Shepstone L; Blyth A; Bachmann M; Harvey I;
    Health Technol Assess; 2010 May; 14(23):1-147, iii-iv. PubMed ID: 20487638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.